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Mitochondria Quality ControlMitochondria are double-membraned highly dynamic organelles; the shape, location and function of which are
determined by a constant balance between opposing fusion and ﬁssion events. A ﬁne modulation of mitochon-
drial structure is crucial for their correct functionality and for many physiological cell processes, the status of
these organelles, being thus a key aspect in a cell's fate. Indeed, the homeostasis ofmitochondria needs to be high-
ly regulated for the abovementioned reasons, and since a) they are themajor source of energy; b) they participate
in various signaling pathways; albeit at the same time c) they are also themajor source of reactive oxygen species
(ROS, the main damaging detrimental players for all cell components). Elaborate mechanisms of mitochondrial
quality control have evolved for maintaining a functional mitochondrial network and avoiding cell damage. The
ﬁrst mechanism is the removal of damaged mitochondrial proteins within the organelle via chaperones and
protease; the second is the cytosolic ubiquitin–proteasome system (UPS), able to eliminate proteins embedded
in the outer mitochondrial membrane; the third is the removal of the entire mitochondria through mitophagy,
in the case of extensive organelle damage and dysfunction. In this review, we provide an overview of thesemito-
chondria stability and quality control mechanisms, highlighting mitophagy, and emphasizing the central role of
mitochondrial dynamics in this context. This article is part of a Special Issue entitled: Dynamic and ultrastructure
of bioenergetic membranes and their components.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Mitochondria are subcellular organelles crucial for the life of the cell.
They are the main energy converters, and are essential components of
various signaling pathways. They are sensors of metabolic homeostasis,
and regulate the levels of intracellular signaling molecules, such as
Ca2+. Ca2+ is buffered in micro-domains at the ER proximity in order
to modulate cytoplasmic signaling, and to support efﬁcient oxidative
phosphorylation and ATP production in the mitochondrial matrix [1].
On the other hand, mitochondria can be detrimental for the cell, being
the major source of reactive oxygen species (ROS), which may oxidizec and ultrastructure of bioener-
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V. Open access under CC BY-NC-ND liand damage proteins, lipids and DNA [2], all of these becoming totally
dysfunctional and dangerous for the cell life.
For all these reasons, mitochondria homeostasis needs to be highly
regulated. Elaborate mechanisms of mitochondrial quality control have
evolved to maintain a functional mitochondrial network and avoid cell
damage. The crucial role of these defense pathways for cellular homeosta-
sis and survival is supported by the fact that mitochondrial dysfunction is
related to aging, cancer and a wide range of neurological pathologies
[3–5]. The cell protects itself by removing or isolating what is damaged,
from mitochondria-located proteins to the same organelles [6,7]. To this
purpose, the cell accomplishes two main strategies. The ﬁrst one is used
to remove misfolded, denatured or oxidized proteins. This strategy is
based both on the activity of mitochondrial proteases that remove pro-
teins resident in the mitochondrial milieu [8,9], and on the activity of
the cytosolic ubiquitin–proteasome system (UPS), which in turn recog-
nizes and removes mistargeted or misfolded mitochondrial proteins be-
fore they reach the organelle, and mediates the degradation of proteins
embedded in the outer mitochondrial membrane (OMM) [10,11].
The second strategy is based on the intrinsic characteristic of mito-
chondria being highly dynamic organelles, continually fusing and
fragmenting in a strictly regulated manner [12,13], and in response
to different physiological needs of the cell [14]. In this second defen-
sive strategy, entire parts of the same organelles are removed. Thus,cense.
Table 1
List of the main physiological and/or patho-physiological processes, in which mitochon-
dria dynamics play a crucial role. The main organelle phenotype is shown, together with
a selected number of correlated references.
Patho-/physiological process Mitochondrial phenotype References
Ca2+ signaling Variable depending on the
pathophysiological condition
Szabadkai et al. [155]
Generation of reactive
oxygen species (ROS)
Fragmentation Yu et al. [156]
Maintenance of dendritic
spines and neuronal
plasticity
Fragmentation Li et al. [157]
Lymphocyte migration Fragmentation and
relocalization
Campello et al. [158]
Metastatic cell migration Fragmentation and
relocalization
Zhao et al. [159]
Muscle atrophy Fragmentation Romanello et al. [160]
Lifespan Fragmentation (in aging) Scheckhuber et al.
[161]
Apoptosis Fragmentation and
cristae-remodeling
Scorrano [162]
Neurodegenerative diseases
(AD, PD, HD, ADOA…)
Mostly fragmentation, in some
cases: cristae disruption,
impaired trafﬁcking,
reduction in number
Corrado et al. [22];
Cho et al. [5]
Cancer Fragmentation Grandemange et al.
[163]; Qian et al.
[164]; Corrado
et al. [22]
Cardiovascular disease Mainly fragmentation Ong et al. [165];
Piquereau et al. [166]
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fragmented phenotype, so as to bemore disposed to segregation and re-
moval [15,16], while healthy or highly active mitochondria tend to fuse
among themselves in order to favor the replacement of essential compo-
nents, as well as maintaining themitochondrial genome in the network
[17–19]. The main mechanism used by the cell to remove damaged or-
ganelles and proteins is autophagy. The term autophagy encloses any
processes regarding cytosolic component degradation via lysosomes.
As we will see in more detail later, the process termedmacroautophagy
is generally responsible for the engulfment and removal of cytosolic
components. However, a more speciﬁc autophagy pathway comes
into play in conditions of severemitochondrial dysfunction, this to selec-
tively remove damaged mitochondria, hence the term ‘mitophagy’.
Albeit beyond the scope of this review, we should also mention a
third level of quality control, which occurs at a cellular level. It takes
place when extensive mitochondrial damage promotes release of pro-
apoptotic factors, so resulting in the cell's suicide through apoptosis [20].
In this review, we provide an overview of the mentioned mecha-
nisms of mitochondria stability and quality control, focusing on the re-
lationships existing between these processes (UPS and autophagy) and
mitochondria dynamics, and on mitophagy, the latter being the princi-
pal process controlling mitochondria homeostasis. Considering the
complexity of the subjects and the impressive amount of data present
in the literature, we will give particular emphasis to recent ﬁndings in
the ﬁeld, focusing on mammals.
2. Outlines on mitochondrial dynamics
As mentioned, mitochondria are highly dynamic organelles, their
shape, location and function being deﬁned by a constant balance and
equilibrium between opposing fusion and ﬁssion events. These dynamic
processes are crucial in many physiological and pathophysiological
cellular conditions, the modulation of the same, being pivotal for deter-
mining cell life and death [14]. Thus, mitochondria morphology needs
to be strictly regulated by a set of ‘mitochondria-shaping’ proteins, the
number of which is constantly increasing. The machineries involved in
mitochondrial fusion and ﬁssion are highly complex; we will only sum-
marize thembrieﬂyhere: For further extensive reading see other reviews
(i.e. [12,21,22]). In mammals, mitofusin 1 (Mfn1) and 2 (Mfn2) together
with OPA1 are required for the fusion of the outer mitochondrial mem-
brane (OMM) and the inner mitochondrial membrane (IMM), respec-
tively. Mfns are integrated in the OMM and form homo- and hetero-
oligomers, which promote tethering and fusion of the OMMs from two
different mitochondria [23,24]. The pleiotropic protein OPA1 localizes
in complexes at the IMM, facing the inter membrane space (IMS),
and drives fusion on the IMM. OPA1 complexes are composed of
post-translational proteolytically cleaved short and long forms, deriving
from the several splicing variants existing [25]. Fusion, along with the
anti-apoptotic role that OPA1 exerts on the mitochondrial cristae struc-
tures [26], requires both the short and long forms of OPA1 [27].
Mitochondrial ﬁssion depends on the GTPase cytosolic dynamin-
related protein 1 (Drp1), which is located in the cytosol and needs to
be activated and to translocate to mitochondria in order to constrict
and cut the organelles [28]. Post-translational modiﬁcations, such
as phosphorylation, SUMOylation and ubiquitylationmodulateDrp1 ac-
tivity so as to ensure adaptation to the various cellular needs [21,29,30].
Furthermore, the OMM protein hFis1 has been proposed as a Drp1 re-
ceptor, being so necessary for mitochondrial ﬁssion. hFis1 mechanism
of action is still highly controversial [31,32]; on the other hand, new
possible Drp1 receptors have been recently identiﬁed: Mff (the OMM-
anchored mitochondrial ﬁssion factor, [32]), and human MIEF1/MiD51
(the OMM-bound mitochondrial elongation factor1/mitochondrial
dynamics 51) with its variant MiD49 [33,34]. The latter were reported
to directly and speciﬁcally recruit Drp1 in a Fis1-independent manner,
but with opposite effects on the mitochondrial morphology, depending
on the protein levels [33–35].Changes in mitochondria morphology inﬂuence crucial physiologi-
cal functions in the cells, such as Ca2+ signaling, generation of reactive
oxygen species, neuronal plasticity and lymphocyte migration [14].
Moreover, the ultrastructure and shape of the organelles have also
been linked to pathophysiological aspects, from muscle atrophy to
lifespan determination, and to apoptosis [14], and are affected in several
human genetic diseases [22] (see Table 1).
The remarkable structural dynamism of mitochondria has a particu-
lar bearing upon the mitochondrial quality control system. The strict
interconnection between mitochondria dynamics and mitochondrial
quality control, detectable at different levels, will be discussed in the
following paragraphs.
3. Mitochondrial proteostasis: the degradation of
mitochondrial proteins
3.1. Mitochondrial proteases and removal of proteins within the organelle
The mechanisms developed by mitochondria to maintain their ho-
meostasis are numerous (see Fig. 1). The ﬁrst line of defense is located
in the organelles and acts at a molecular level in conditions of mild
mitochondrial damage. It consists of several proteases and chaperones
operating within the mitochondrion [36].
Themajority of themitochondrial proteins are synthesized in the cy-
tosol and subsequently imported into the organelle [37]. The unwanted
but probable interaction and aggregation among proteins entering the
organelle in a relatively unfolded state are prevented by a group of
chaperones, members of the heat shock family [38].
A highly conserved group of proteases is responsible for the removal
of unfolded or damaged proteinswithin themitochondria. For example,
in concert with chaperones, the AAA+ (ATPase associated with a wide
variety of cellular activities) soluble hLonprotease family removes dena-
tured or oxidatively mildly damaged proteins [39,40]. A second soluble
protease group belongs to the bacterial Clp protein family (caseinolytic
protease [41]), mitochondrially represented by mtClpXP (chaperone-
protease complex), the activity of which is still undeﬁned. The
inner mitochondrial membrane (IMM) is highly enriched in proteins,
which are more susceptible to oxidative damage due to their proximity
Fig. 1. Schematic representation of the mitochondrial degradation main mechanisms. On the left, the chaperone systemwith some of the main players indicated. Hsp70, Hsp90 families'
members (in violet) help nuclear encoded proteins to enter the mitochondria in an unfolded state (Up, unfolded protein). Moreover, mtHsp70 and, in some conditions, Hsp60/Hsp10
members facilitate protein folding within the mitochondria. Centered in the depiction, the mitochondria protease system is represented, with the main protease classes shown. Lon and
Clp protein families are dedicated to degradation of damaged or unfolded proteins in thematrix. Unassembled or damaged innermembrane proteins are degraded by themembrane em-
bedded AAA+ proteases, them-AAA+ and the i-AAA+, facing thematrix or the inter-membrane space, respectively. Somemembers of both protease classes are shown (in green). i-AAA+
YME1L andm-AAA+ (the latter in complexwith Prohibitins (Phbs)) are responsible for OPA1 processing and complex formation, composed by short and long forms. On the contrary, the
m-AAA+ Oma1 degrades the long OPA1 form, under stress conditions. Also the i-AAA+ HtrA2/Omi participate to the turnover of misfolded inter-membrane space proteins. On the right,
some players of the ubiquitin–proteasome system (UPS), important in the regulation of mitochondria homeostasis and shape, are represented. Outermembrane proteins are ubiquitylated
(Ub, and yellow spring indepiction) by a cascade of E-ligases to be removed then through theubiquitin–proteasomedegradation system. Someexamples:Mfns,Nemo, Drp1, Fis1,Miro are
alternatively ubiquitylated byMarch5, Parkin in order tomodulatemitochondrial dynamics, by respectively impinging in the fusion (Mfns and Nemo), ﬁssion (Drp1 and Fis1) or transport
(Miro) of mitochondria. These machineries are activated under stress/damage conditions (promoting ﬁssion) or in response to physiological conditions requiring high efﬁciency in ATP
production or componentmixing (promoting fusion in this case).Mfn2 is also independently deubiquitylated byUbp2andUbp12. Cdc48 helps in extracting the outermitochondrialmem-
brane embedded protein (here it is shown acting on Fis1, as an example). In case of excessive mitochondria damage, the same organelles are removed through mitophagy.
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is crucial; two membrane-integrated AAA+ metalloprotease com-
plexes, belonging to the FtsH (filament-forming temperature-sensitive)
protease family, ensure this function [41,42]. The m-AAA protease is di-
rected and works in the matrix, while the i-AAA works facing the inter-
membrane space (IMS) [43]. An example of i-AAAprotease is thehuman
Omi/HtrA2, whose levels increase in response to various stresses, and
for which a role has been proposed in autophagy [44] and in apoptosis
[45,46].
Interestingly, these proteases form a hexamer in solution, creating a
sort of ring-like structure with a proteolytic cavity, where substrates
enter to be cleaved [47]. Of note, in mammals, the proteases m-AAA,
YME1L (an i-AAA protease) and the metallopeptidase OMA1 (overlap-
ping activity with m-AAA protease 1) are, in various ways, responsible
for the cleavage of one key protein controlling mitochondria fusion,
OPA1 (see above; [27,48–50]). In this way, theymodulatemitochondria
morphology. Another intriguing regulation of mitochondria shape and
stability comes from a class of IMM proteins, the prohibitins [51,52].
These molecules apparently function as scaffold proteins, forming
a complex together with m-AAA [53,54] and orchestrating OPA1 pro-
cessing as well. Lack of prohibitins increases the proteolitic activity of
m-AAA, consequently destabilizing the long form of OPA1 and leading
to fusion inhibition [51,52].
3.2. The UPS and ubiquitylation system: removing proteins from the outer
mitochondrial membrane
Mitochondrial protein quality control is also inﬂuenced by the
ubiquitin–proteasome system (UPS, see Fig. 1) [10,55,56]. UPS isthe major nonlysosomal system for degrading proteins in the cell.
It is involved in regulating a plethora of biological functions. In eukary-
otes, the UPS is a conserved proteolytic process, composed of the E1
(ubiquitin activating), E2 (ubiquitin conjugating), and E3 (ubiquitin
ligating) enzymes. Together these cooperate in mediating attachment
of ubiquitin (monomers or chains) to a multitude of target proteins,
then recognized and degraded by the proteasome. The proteasome is
constituted of the 19S regulatory unit and the 20S core unit, responsible,
respectively, for the recognition and proteolysis of the ubiquitylated sub-
strates [57]. Several mitochondrial E3 ligases have been recently identi-
ﬁed [10] as being regulators of the mitochondria fusion/ﬁssion balance
by directly targeting the ‘mitochondria-shaping’ proteins. Nevertheless,
the physiological role of these ligases is still controversial and unclear,
and further studies are needed to clarify their action mechanism.
MARCH5/MITOL is an important E3 ligase showing opposite effects on
mitochondriamorphology. It has been shown, inworks that seem to con-
tradict each other, that 1) it mainly binds Drp1 and Fis1 and thus blocks
ﬁssion [58,59]; 2) it activates Mfn2 and fusion [58]; and 3) it binds and
degrades Mfn1 by promoting ﬁssion [60], especially in the cell's G2/M
phase [61]. Recentworks have also reported a role forMARCH5 in themi-
tochondrial quality control in nitrosative stress responses [62,63].
The MULAN/MAPL E3 ligase causes mitochondrial fragmentation by
directly mediatingMfn2 ubiquitylation and degradation [64], thus facil-
itating mitochondria removal via mitophagy (see below). Interestingly,
Mfn2 activity is not only regulated by ubiquitylation, but also by the
deubiquitylases Ubp2 and Ubp12, through independent pathways
[65]. MULAN/MAPL is the ﬁrst mitochondrial-anchored SUMO E3
ligase characterized [66]. It regulates the structure of mitochondria not
only through Mfn2 ubiquitylation, but also by directly controlling the
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thus stimulating mitochondrial ﬁssion. These ﬁndings deﬁne for the
SUMOylation process an important role in regulating mitochondrial
quality control. SUMOylation is another crucial mechanism controlling
the stability and the ubiquitin-dependent degradation of mitochondrial
proteins. At variance with what has been assumed for a long time,
i.e. that SUMO was acting as a ubiquitin antagonist, it is now known
that SUMO conjugation can mediate ubiquitin-dependent degradation
by the proteasome, the two processes functioning in a tightly integrated
and cooperative manner [67].
A few cytosolic E3 ligases, such as Parkin, Huwe1/Mule/HectH9 and
the yeast Mdm30 of the CRL E3 complex, regulate themitochondriamor-
phology mainly through Mfn2 (or the yeast homolog Fzo1) degradation,
conferring on the UPS a key role on the regulation of mitochondrial
shape [68–70]. As described later, upon CCCP treatment, Parkin mediates
ubiquitylation and removal ofMfns, so inducingmitophagy. Interestingly,
Drp1 also is a substrate of Parkin in unstressed conditions [71], indicating
again that E3 ligases may change their role depending on the physiologi-
cal cell conditions. It should be noted that, under cellular stress, a very re-
cent paper has shown that Parkin increases linear ubiquitylation of NF-κB
essential modulator (NEMO), resulting in OPA1 transcriptional up-
regulation, this maintaining mitochondria integrity and protecting the
cell from stress-induced cell death [72].
Finally, UPS has also recently been found tomodulate themitochon-
dria motility, through Parkin-dependent degradation of Miro (an OMM
protein involved in mitochondrial transport along microtubules) [71].
Again, the arrest of mitochondria movement (together with a small
size) may also facilitate mitophagy.
The question now arises as to how exactly the cytosolic proteasome
is able to degrade integral mitochondrial membrane proteins. A key role
for the AAA+ ATPase VCP/p97 (Cdc48, in yeast) in this process has re-
cently been demonstrated, even though other mechanisms of mito-
chondrial protein retro-translocation may exist, since the loss of p97
function does not completely abrogate protein degradation through
the proteasome [73]. This chaperone would facilitate the extraction of
substrates embedded in the OMM [74]. In the case of Mfn1 and Mcl1,
for example, the two proteins are retro-translocated frommitochondria
to the cytosol, prior to, or concurrent with, proteasomal degradation, in
a p97 ATPase domain-dependent manner [75]. Of note, indeed, it has
been demonstrated that also p97 associateswithmitochondria inmam-
malian cells [76]. These results suggest a conserved role for AAA-ATPase
protein familymembers in the regulation of mitochondrial proteostasis.
Moreover, the fact that p97 mediates degradation of pro-fusion mito-
chondrial proteins leading to increased mitochondria fragmentation,
in concert with the interesting observation that proteasomal inhibitors
such as lactacystin and MG132 also inhibit mitochondria degradation
[77], create a link between p97 activity and mitophagy.
Importantly, the UPS-dependentmitochondria control is regulated at
different levels: the E3 ligases transcripts are tissue speciﬁc [78]; various
proteins regulate the E3 ligase functions [79]; E3 ligase activity, as well
as the substrate selectivity, is under the control of post-translational
modiﬁcations, such as phosphorylations [71] or S-nitrosylations [80];
E3 ligases also autoubiquitinate and degrade themselves [59].
In higher eukaryotes, a mitochondria-speciﬁc unfolded protein
response (UPR) is also present, to attenuate as well the increase of
misfolded proteins in mitochondria [81,82].
4. Mitochondria stability and consequent changes in their shape:
opposite responses to autophagy
4.1. Outlines on autophagy
Autophagy (from Greek, meaning self-eating) is a catabolic process
occurring in all eukaryotic cells, bywhich cytoplasmicmaterial (e.g., pro-
teins, lipids and organelles) is degraded through the lysosome machin-
ery. This process involves de novo formation of double-membranedvesicles, termed autophagosomes, which sequester the cytoplasm-
derived materials and transport them to the lysosomes for degradation.
There are three classes of autophagy: microautophagy, chaperone-
mediated autophagy (CMA), andmacroautophagy [83].Macroautophagy
is well conserved from yeast to mammals and is the predominant
pathway of autophagy. The non-selective autophagy (bulk autophagy)
is induced by starvation while selective autophagy is induced when
organelles (such as mitochondria, and in this case the process is called
mitophagy) are damaged or unwanted in the cell.
Autophagy is regulated in ﬁve steps 1) initiation of the isolation
membrane 2) elongation of it, 3) closure of the isolation membrane
and autophagosome nucleation, 4) autophagosome–lysosome fusion
and 5) lysosomal degradation [84]. These ﬁvemechanisms are also sim-
ilar during the selective removal ofmitochondria [85]. Thanks to genetic
screens in yeast Saccharomyces cerevisiae, 35 genes regulating autopha-
gy (ATGs) have been identiﬁed [86]. ATGs are well conserved in mam-
malian cells and, except for ATG13, the core machinery involved in
non-selective autophagy is also involved in selective autophagy, such
as mitophagy [87].
4.2. Different types of autophagy and different cell needs induce different
mitochondrial shaping pathways
When the mitochondria damage becomes too extreme for the
cell and is accompanied by dissipation of the mitochondrial membrane
potential, the fusion process is blocked; mitochondria are selectively
removed by autophagy, precisely through mitophagy [68,88], with a
characteristic phenotype of fragmented organelles. Interfering with
mitochondrial ﬁssion inhibits the autophagic degradation of damaged
mitochondria [74,89], this illustrating the intimate relationship be-
tween mitochondrial dynamics and quality control. The fact that mito-
chondria are fragmented during this process, is probably attributable
to sterical constrains. Indeed, large or elongated mitochondria would
be sterically problematic for autophagosomes engulfment, while
small fragmented organelles would easily ﬁt within those structures.
For this reason, it has been suggested that mitochondrial fragmenta-
tion precedes mitophagy [17,18,89,90]. In fact, this was proven in
yeast by Nowikovsky and colleagues [91], even though a more recent
work has shown that rapamycin induces mitophagy in the same or-
ganisms, independently of mitochondria ﬁssion, raising doubts about
ﬁssion's role during this selective autophagy [92]. From what is
known to date, we can conclude that mitochondria ﬁssion is not able
to trigger mitophagy per se; the dysfunction of the organelles, or other
unknown signals, are otherwise required. An elegant recent work
showed the existence of a selection process that distinguishes ‘good’
from ‘bad’mitochondria, targeting only the former to autophagosomes
engulfment [18].
Macroautophagy is an energy-consuming process which, to protect
the cell from damage, needs high amounts of ATP i.e., namely, highly
functional mitochondria. In this context, mitochondria unbalance
the morphological equilibrium toward fusion. Indeed, elongated or-
ganelles have more cristae, with increased ATP synthase activity and,
consequently, more ATP production. Furthermore, an entire mitochon-
drial network is sterically far from being engulfed by autophagosomes
during autophagy. Thus, mitochondria protect themselves from au-
tophagic removal by blocking the ﬁssion machinery and promoting
fusion. This is exactly what Scorrano and colleagues [19] also nicely
showed in vivo (as conﬁrmed in parallel by another independent
study [15]), when macroautophagy was induced by starvation or
mTOR inhibition. The mechanism regulating this process is based on
the increase of cAMP levels induced by starvation. cAMP activates
PKA which phosphorylates Drp1 Ser637, thus blocking its activation
and its capability to induce fragmentation. In summary, we can con-
clude that mitochondria morphology determines the cellular fate
by opposing different phenotypes in response to different types of
autophagy.
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As already said above, when mitochondria are defective, the cell
removes them through the mitophagic process (Fig. 2). Mitophagy is
also a mechanism which regulates the number of mitochondria in re-
sponse to developmental signals. Indeed, two types of mechanism can
be described on this regard: 1) ‘programmed’ mitophagy, in the case
of reticulocyte differentiation [93] and during elimination of parental
mitochondria in the fertilized oocyte [94,95]; and 2) ‘reactionary’
mitophagy when mitochondria are defective. According to these two
programs of mitophagy, three well-known effectors emerge: First is
Nix/BNIP3L, a protein resident on mitochondria [96–98] and the main
player of mitophagy during reticulocyte differentiation; second and
third are PINK1 [99] and Parkin [100], two genes linked to autosomal-
recessive juvenile Parkinsonism in humans and involved in mitophagy
when mitochondria are damaged. PINK1 is a mitochondrially targeted
serine/threonine kinase, whereas Parkin is an E3 ubiquitin ligase, as
we said above.
5.1. Classical effectors of mitophagy
Selective mitophagy is necessary during development of red blood
cells (RBCs). In fact, these cells need to lose their mitochondria in order
to transport and not consume oxygen [93]. Mitophagy in RBCs involves
Nix, a Bcl-2 related OMM protein, with an atypical BH3 domain. Nix
participates in the incorporation of mitochondria into autophagosomes
by using its LC3-binding motif [101]. Consequently, in this context, Nix
functions as a receptor targeting mitochondria for degradation. Another
type of programmedmitophagy occurs during elimination of parentalmi-
tochondria in the fertilized oocyte [94]. However in this situation, no clear
actor has been yet deﬁned, even though it seems clear that the autophagic
machinery is required [102–104]. Interestingly, in fertilized oocytes,mi-
tochondria ubiquitylation is a controversial issue: the organelles have
been shown to be not ubiquitylated prior to degradation (103–105),
whereas others studies indicate that ubiquitylation of parental mito-
chondrial proteins occurs, indeed, prior to degradation [77,95,105].Fig. 2.Mitophagymodels inmammalian cells. Themitophagicmechanism in the presence of Pa
FUNDC1 are themain effectors of mitophagy and are represented on the central part of the draw
machinery, such as Ambra1, Beclin 1, namely resident on mitochondria, could also play a role
expanding to mitochondria.In addition, it is not clear if mitochondria are depolarized or not be-
fore engulfment by autophagosomes (Fig. 3). Further investigations are
required to better characterize this pathway.
To date, a body of evidence places the PINK1/Parkin couple as the
major pathway of mitophagy in immortalized cells. Even if many ques-
tions remain, this pathway is the best described for the mitophagic
degradation of dysfunctional, depolarized-mitochondria. A strong de-
crease in mitochondrial potential induced by the uncoupler CCCP,
leads to PINK1's recruitment to the OMM, through the TOM20 complex
[106–109]. In this manner, PINK1 works as a sensor of mitochondrial
potential. In a second step, PINK1 recruits Parkin from the cytosol,
phosphorylates it and promotes Parkin's E3 ubiquitin ligase activity
[110–114]. Then, ubiquitylated mitochondria recruit ubiquitin-binding
adaptor proteins, such as p62/SQSTM1 [110,115,116]. Nevertheless,
some studies exclude p62 from this pattern [96,110,115]. The binding
ofmitochondria to p62 is followed by clustering ofmitochondria around
the nucleus [110,115,116]. LC3 is needed as a scaffold protein recruiting
the autophagic machinery [68]. A direct link with the classical autopha-
gy machinery does, indeed, exist. In fact, PINK1 and Parkin can interact
with the Beclin 1–PI3K complex [117,118]. AMBRA1, an activator of the
Beclin 1 complex, is recruited by Parkin to mitochondria in order to
activate the Beclin 1 complex [117].
5.2. PINK1/PARKIN independent pathways
The mitophagic PINK1/Parkin pathway has been demonstrated
as being relevant in cases of mitochondrial damage. Indeed, in most re-
lated studies, the mitochondrial uncoupler CCCP is the best agent to in-
duce mitophagy. However, it is not known yet what happens in cells
upon a physiological induction of mitophagy. Are PINK1/Parkin acting
under physiological conditions? The fact that 1) patients with muta-
tions in the PINK1/Parkin pathway do not show an increasedmitochon-
drial mass, and 2) the most prominent pathology of adult Parkin null
ﬂies is in the ﬂight musculature, which is plagued by muscle degenera-
tion and pronounced mitochondrial lesions [119], leads to the conclu-
sion that other pathways independent of PINK1/Parkin do, indeed,rkin, is represented on the left of the drawnmitochondrion.When Parkin is absent, Nix and
nmitochondrion. Finally, on the right part of themitochondrion, proteins of the autophagic
in selective mitophagy by serving as scaffold proteins to directly recruit the phagophore
mito-RFP LC3 Merge 4,5X
Fig. 3.Mitochondrial engulfment by autophagosomes. HEK293 cells were transfected with vectors encoding mito-RFP (red) and a Parkin-overexpressing construct. Twenty-four hours
after transfection, cells were treated with CCCP in order to induce mitophagy, ﬁxed and stained with an anti-LC3 antibody (green). The merge of the ﬂuorescence signals is shown in
the right panel, together with a highermagniﬁcation image (4.5×). Of note, in these conditions, mitochondria-containing autophagosomes are visible in a sort of large aggregate, termed
mito-aggresome. Scale bar, 6 μm.
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sion is strengthened by the fact that PINK1 or Parkin knock-outmice do
not present strong phenotypes as expected in caseswhere the damaged
mitochondria removal is totally abrogated [120]. Additional studies
illustrate the fact that the PINK1/Parkin pathway is not the universal
mitophagic pathway in cell lines. First, it has been shown that Nix func-
tion is not restricted to erythrocyte differentiation: In HeLa cells, a cell
line free of Parkin, the binding of Nix and LC3 increases following
CCCP treatment [97,121]. This work suggests a parallel function of Nix
in mitophagy upon mitochondrial damage. Second, it has been shown
that Nix is involved in mitophagy also following hypoxia in human
ﬁbroblasts [101]. During this process, necessary to remove ROS produc-
tion, Nix expression increases and disrupts the Bcl-2–Beclin 1 binding,
thus increasing ATG5-dependent autophagy [122]. Moreover, in the
context of hypoxia, a novel player of mitophagy has been found:
FUNDC1 [123]. Indeed, FUNDC1 binds LC3 protein through its LIR
motif and helps the mitochondria engulfment by autophagosomes.
In conclusion, Nix can participate in different mitophagy pathways.
In particular, it appears to be able to substitute PINK1/Parkin when
they are absent. Moreover, the characterization of a new actor on
mitophagy, FUNDC1, underlines the fact that other mitophagic ways
exist and maybe are activated differentially according to the stimulus
and/or the cell type.
Interestingly, the PINK1/Parkin pathway of mitophagy has been
characterized in non-neuronal cell lines. For what concerns neurons,
different behaviors of Parkin have been published. In one case, it has
been observed that after depolarization of neuronal mitochondria,
Parkin is not recruited to the organelles and their clearance does not
occur [124]. On the other hand, various studies indicate that Parkin is re-
cruited to damaged mitochondria [125,126]. The physiological rele-
vance of PINK1/Parkin pathway cannot be addressed for all cell lines;
other studies are required to a better understanding of mitophagy in
neurons. Certainly, new players in neuronal mitophagy will emerge
and contribute to the discovery of novel therapeutic targets for neuro-
degenerative diseases.
Since all the pathways described hitherto converge on the core
apparatus of autophagy, some core autophagy apparatus proteins likely
control the mitophagic process directly. Recently, it has been demon-
strated that conjugated LC3 proteins can act as scaffolds to recruit
various proteins to the phagophore. The interactions with ATG8 homo-
logues occur thanks to a LIR (LC3-interacting region) motif. This motif
was found in p62 for the ﬁrst time [127,128] but subsequently has
been found in several other proteins as well [129]. Despite their speciﬁc
binding to ATG8 family proteins, these molecules with a LIR motif
are not always autophagy substrates, underlining the fact that LIR-
mediated interactions with ATG8 are also used to scaffold proteins
on the surface of autophagosomes. It should be pertinent to examine
among the proteins of the autophagy core apparatus, which one can lo-
calize tomitochondria or which other can be recruited tomitochondria,
and, this being the case, which possesses such a LIR motif. Indeed,
among these proteins, a very good candidate has emerged in recent
years to act as a catalyzer of mitophagy.An endogenous pool of AMBRA1 (a component of the autophagy ini-
tiation complex, see above) has been shown to be localized at themito-
chondria [130]. Moreover, a tandem afﬁnity puriﬁcation and mass
spectrometry allowed identifying AMBRA1 as an interactor of Parkin.
Interaction found to increase strongly during prolonged mitochondrial
depolarization, even though no Parkin-dependent ubiquitylation of
AMBRA1 has yet been identiﬁed. Ambra1 is important for themitochon-
drial clearance and not for Parkin translocation tomitochondria [117]. It
would be of interest to investigate the role of mitochondrial AMBRA1 in
mitophagy. AMBRA1 can be found associated in complex with ATG4
[131]; thus, it could recruit, through a potential interaction with LC3,
the autophagic machinery to mitochondria in order to remove them.
Interestingly, AMBRA1 can bind the E3 Ubiquitin ligase TRAF6 [132].
It would be interesting to investigate whether the binding betweenmi-
tochondrial AMBRA1 and TRAF6 is an important event onmitochondria
ubiquitylation. However, other candidates could also help AMBRA1
to ubiquitylatemitochondria. In fact, Ambra1 has been found to be asso-
ciated with CUL4-DDB1 (a E3 ubiquitin-protein ligase complex com-
prising the large subunit of the damaged DNA-binding protein complex
(the DDB complex), required for DNA repair) [131,133].
Another autophagy core apparatus protein, found localized at
themitochondria is Beclin 1. Mitochondrial Beclin 1 could play an addi-
tional role to recruit the autophagic machinery to help mitochondria
engulfment. In fact, a recent work indicates that Beclin1 possesses a LIR
motif in its sequence [134]. Thus, we can speculate that Beclin 1 could
have this crucial recruiter role on some mitophagic contexts. Further
studies are required to clarify Beclin 1's function at the mitochondria.
6. Pathological implications in neurodegenerative diseases
Wehave reported in this reviewhow imperative it is, in thepresence
of misfolded or damaged proteins, that these ‘bad’ molecules be
removed from the cell to prevent the formation of toxic folding interme-
diates, aswell as the accumulation of lethal protein aggregates. Incorrect
functionality of the protection machineries is often linked to severe
diseases and to aging. Several neurodegenerative diseases share a com-
mon pathogenic mechanism, in which aggregates of a particular protein
form and accumulate in the cytosol, the nucleus, or in themitochondria.
Examples are: accumulation of the amyloid-b peptide in Alzheimer's
disease [135,136], accumulation of a-synuclein in Parkinson's disease
[137], and aggregation of a mutant form of the huntingtin protein in
Huntington's disease [138]. Although the exactmechanismof pathogen-
esis for these diseases remains unknown, mitochondrial dysfunction is
implicated in their progression. This fact causes loss of neurological
cell populations, since they are particularly sensitive to the quality of
mitochondria [139]. Many diseases are related to the different steps of
mitochondrial quality control. At the IMM level of protein degradation,
for example, the importance of a proper quality control is highlighted
by the ﬁnding that mutations in paraplegin and Afg3l2 proteins
(the two subunits constituting the protease m-AAA in humans) lead
to the neurological diseases hereditary spastic paraplegia (HSP) and
spinocerebellar ataxia type 28 (SCA28), respectively [140,141].
457S. Campello et al. / Biochimica et Biophysica Acta 1837 (2014) 451–460Interestingly, neuron-speciﬁc ablation of prohibitin2 in the mouse
forebrain causes tau hyperphosphorylation and ﬁlament formation
in the hippocampus, with consequent behavioral impairments. The
mechanism underlying these observations is impairment of OPA1 sta-
bility, affecting mitochondria ultrastructure and inducing accumulation
of aberrant mitochondria [142].
Also an aberrant UPS function has been reported in many neuropa-
thologies such as Parkinson's diseases [143], ischemia [144] and age-
related Alzheimer's disease [145].
Alterations in mitophagy pathway can be found in several neurode-
generative diseases [146]. Parkinson's-disease (PD)-associated genes,
such as PINK1 and Parkin are involved in mitophagy, as previously
said. It is thus expected that in PD brain, removal of mitochondria is dis-
turbed and that the dopaminergic neurons are dying. However, the role
of these proteins in physiological conditions remains to be elucidated.
In Alzheimer's disease (AD), Parkin is able to reduce intraneuronal
amyloid-β levels in lentiviral models [147]. In addition, Parkin is able
to ubiquitylate intracellular amyloid-β in vivo and can stimulate
autophagy and clearance of defective mitochondria [147]. Mitochon-
drial dysfunction has also been associated with Huntington's disease
due to deregulation of PGC1-α, a transcription factor important for mi-
tochondrial biogenesis [148]. The mechanisms and role of mitophagy
in these neurodegenerative diseases need further investigation.
Finally, other alterations in mitochondria function not strictly re-
lated to their quality control but rather to their transport or shape
are linked to neurodegenerative diseases. In some sporadic cases of
Alzheimer's disease (AD), trafﬁcking alteration has been observed, for
example, due to mutation in Kinesin1 [149]. Works using a mouse
model for Huntington's disease (HD), produced similar results. Mutated
Htt (the gene of huntingtin protein) is able to block mitochondrial
movement [150], by causing a redistribution of kinesin and dynein
in primary cortical neurons [151]. On the other hand, mutations in
mitochondria-shaping proteins are also directly related to neurodegen-
erative diseases, such as autosomal dominant optic atrophy (ADOA) and
Charcot–Marie–Tooth disease type 2A, deriving frommutations inOPA1
and Mfn2, respectively [152–154].
7. Comments and conclusions
Although mitochondria are essential for determining the cell fate,
supporting its energy balance and regulating its dismissal through a di-
rect control of apoptosis, we only recently acquired sufﬁciently detailed
molecular insights about the destiny of the mitochondria within
the cells. Whilst several proteins have been shown to participate
in the degradation of individual mitochondrial proteins, either for
recycling the entire protein set of the organelle or for regulating the
half-life of speciﬁc targets, surprisingly few factors seem to be involved
in mitophagy. However well established their role in neurodegenera-
tion, the relevance of Parkin and Pink1, to date the main two actors in
this scenario, still remains in doubt under physiological conditions.
Other newmolecules, related to autophagy regulation,may play impor-
tant roles in this context.
Besides its crucial role in the nervous system, mitochondria homeo-
stasis is certainly involved in cancer ontogenesis and progression.
Although discussion of this issue is beyond this paper's scope, we can
share here the knowledge that damaged mitochondria may impact
the oxidative balance of the cells and stimulate DNA damage and chro-
mosomal instability. Mitophagy (and the proteasomal degradation
ofmitochondrial factor) can thus also be considered as a forefront target
pathway both in cancer and, more generally, in human metabolic
disorders.
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